Brand
Hikma Pharmaceuticals USA Inc.
3 federal recalls on file. We monitor every CPSC, FDA, USDA, and NHTSA notice for Hikma Pharmaceuticals USA Inc. and translate it into plain English — free weekly digest, optional same-day alerts.
- 2025-08-06FDA-DrugClass IILorazepam Injection, USP, 2 mg/mL, 25 x 1mL vials/carton, Rx Only, Manufactured by: Hikma Berkeley Heights, NJ 07922, NDC# 0641-6044-25
Failed Impurities/Degradation Specifications: An out-of-Specification for total related compounds
- 2024-08-28FDA-DrugClass IAcetaminophen Injection, 1,000 mg per 100 mL (10 mg/mL), 100 mL Single Dose bags, For Intravenous Use Only, Rx Only, Manufactured by: Hikma Farmaceutica (Portugal), SA, distributed by Hikma Pharmaceuticals USA Inc Berkeley Heights, NJ NDC 0143-9386-01
Labeling: Label Mix-up: a bag of Dexmedetomidine HCl in 0.9% Sodium Chloride Injection was found inside an overwrap labeled Acetaminophen Injection 1,000 mg per 100 mL (10 mg/mL)
- 2024-03-27FDA-DrugClass IIInfumorph (Preservative-free Morphine Sulfate Sterile Solution), 20 mL ampul, Rx only, Manufactured by Hikma Berkeley Heights, NJ 07922, NDC 0641-6039-01
The filter included in the carton has an expiration date that has expired prior to the expiration date of the actual product lot.
Get notified about new Hikma Pharmaceuticals USA Inc. recalls
Free weekly digest. We email when a new federal recall affects Hikma Pharmaceuticals USA Inc. or anything else in your household.
Get the Sunday Brief